$VRCA News

HC Wainwright & Co. Assumes Verrica Pharmaceuticals at Buy, Announces Price Target of $12

Transcript: Verrica Pharmaceuticals Q1 2026 Earnings Conference Call

Verrica Pharmaceuticals Inc. (VRCA) Q1 2026 Earnings Call Transcript

Verrica Pharmaceuticals (NASDAQ:VRCA) Q1 Results Beat Revenue Estimates as Pipeline Progress and Record Demand Drive Positive Momentum

Verrica Pharmaceuticals Q1 Adj. EPS $(0.41) Misses $(0.38) Estimate, Sales $5.023M Beat $4.520M Estimate

Verrica Pharma To Present Phase 2 Clinical Data Highlighting Potential Abscopal Effects Of Oncolytic Peptide, VP-315, In Treatment Of Basal Cell Carcinoma At 2026 SID Annual Meeting

Verrica Pharmaceuticals Reveals Acceptance Of A Late-breaking Abstract Reporting Phase 2 Exploratory Data Of VP-315; Data To Be Presented At The Upcoming 2026 Society for Investigative Dermatology Annual Meeting

Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference

Verrica Pharmaceuticals Inc (VRCA) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ...

Verrica Pharmaceuticals Q4 Earnings Call Highlights

Verrica Pharmaceuticals Inc (NASDAQ:VRCA) Reports Q4 Earnings Beat and Accelerating Revenue Growth

Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Verrica Pharmaceuticals Inc. (VRCA) Q4 2025 Earnings Call Transcript

Verrica Pharmaceuticals Q4 Adj. EPS $(0.51) Beats $(0.79) Estimate, Sales $5.092M Beat $4.525M Estimate

Earnings Outlook For Verrica Pharmaceuticals

Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 11, 2026

Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference

Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer

Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical

Verrica Pharma Announces Launch Of YCANTH In Japan By Its Partner, Torii Pharma, For Treatment Of Molluscum Contagiosum